Following encouraging trial findings , retatrutide, a novel peptide treatment for treating adult-onset hyperglycemia , has secured conditional approval from the Healthcare and Regulatory Agency (MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/